Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Apricus Biosc Inc (APRI)

2.25 -0.04 (-1.75%)

3/24/2017  4:00pm

Open:

2.40

Pre. Close:

2.29

High:

2.40

Low:

2.25

Volume:

66,386

Market Cap:

17.42M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.43 - 2.49

2.49 - 2.55

Low:

2.12 - 2.17

2.17 - 2.23

Close:

2.17 - 2.25

2.25 - 2.33

Technical analysis  (as of: 2017-03-24 4:31:52 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 3.26     One year: 4.08

Support:

Support1: 1.65    Support2: 1.37

Resistance:

Resistance1: 2.79    Resistance2: 3.49

Pivot:

2.45

Moving Averages:

MA(5): 2.23     MA(20): 2.56

MA(100): 2.04     MA(250): 3.22

MACD:

MACD(12,26): -0.12     Signal(12,26,9): -0.06

%K %D:

%K(14,3): 35.04     %D(3): 33.65

RSI:

RSI(14): 40.66

52-Week:

High: 4.07  Low: 0.26  Change(%): -63.7

Average Vol(K):

3-Month: 1373  10-Days 245

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
APRI has closed above bottom band by 30.3%. Bollinger Bands are 0.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 20 Jan 2017 05:48:45 GMT
Apricus Biosciences Inc (NASDAQ:APRI) Looks Cheap, Even With Recent Gains

Thu, 09 Mar 2017 16:52:30 GMT
Thursday's Market Insights: Apricus Biosciences Inc (APRI), VIVUS, Inc. (VVUS ...

Tue, 14 Mar 2017 12:51:54 GMT
Apricus Biosciences Inc (NASDAQ:APRI) Releases Corporate Update

Wed, 09 Nov 2016 02:37:30 GMT
Apricus Biosciences' (APRI) CEO Rich Pascoe on Q3 2016 Results - Earnings Call ...

Mon, 31 Oct 2016 11:33:10 GMT
Reverse Stock Split: Apricus Bio

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

7.74

Shares Float (M)

5.69

% Held by Insiders

% Held by Institutions

Shares Short (K)

772

Shares Short Prior Month (K)

949

Stock Financials

EPS

-1.620

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

-0.980

PEG Ratio

Profit Margin

-117.80

Operating Margin

-203.29

Return on Assets (ttm)

-113.4

Return on Equity (ttm)

Qtrly Rev. Growth

239.1

Gross Profit (p.s.)

0.242

Sales Per Share

1.039

EBITDA (p.s.)

-2.072

Qtrly Earnings Growth

Operating Cash Flow (M)

-11.67

Levered Free Cash Flow (M)

-7.18

FoxReading.com

Valuation

P/E

-1.39

P/E Growth Ratio

-0.02

P/BV

-2.30

P/S

2.17

P/CF

-1.49

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

0.067

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.